
RPG Life Sciences Ltd is Rated Sell
2026-03-15 10:10:02RPG Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance.
Read full news article
RPG Life Sciences Ltd Valuation Shifts to Fair Amidst Sector Comparisons
2026-03-13 08:00:25RPG Life Sciences Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade amid evolving market dynamics. This article examines the implications of changes in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, comparing them with historical averages and peer benchmarks to assess the stock’s price attractiveness.
Read full news article
RPG Life Sciences Ltd Falls to 52-Week Low Amidst Continued Downtrend
2026-03-04 10:50:18RPG Life Sciences Ltd touched a new 52-week low of Rs.1767.25 today, marking a significant decline in its stock price amid broader market fluctuations and sectoral underperformance. The stock has experienced a consecutive three-day fall, accumulating a loss of 6.8% over this period, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.
Read full news article
RPG Life Sciences Ltd Stock Falls to 52-Week Low of Rs.1767.25
2026-03-04 10:50:09RPG Life Sciences Ltd has declined to a fresh 52-week low of Rs.1767.25, marking a significant downturn in the stock’s performance amid broader market fluctuations and sector-specific pressures. The stock has underperformed its sector and the broader market over the past year, reflecting a combination of subdued financial metrics and market sentiment.
Read full news article
RPG Life Sciences Ltd is Rated Sell
2026-03-04 10:10:02RPG Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
RPG Life Sciences Ltd Falls to 52-Week Low Amidst Market Downturn
2026-03-02 16:03:39RPG Life Sciences Ltd has recently touched a 52-week low, closing near Rs 1772.05, marking a significant decline in its stock price amid broader market weakness and sector underperformance. The stock’s recent trajectory reflects a combination of subdued financial growth and market pressures within the Pharmaceuticals & Biotechnology sector.
Read full news article
RPG Life Sciences Ltd: Valuation Shift Enhances Price Attractiveness Amid Sector Challenges
2026-02-24 08:01:01RPG Life Sciences Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite a recent downgrade in its overall mojo grade to Sell. This change is primarily driven by improvements in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the stock as a more compelling option within the Pharmaceuticals & Biotechnology sector amid mixed market returns.
Read full news article
RPG Life Sciences Ltd is Rated Sell
2026-02-21 10:10:05RPG Life Sciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article
RPG Life Sciences Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-02-17 08:02:36RPG Life Sciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s Mojo Grade was downgraded from Hold to Sell on 16 Jan 2026, reflecting deteriorating technical conditions amid a broader market context that has seen the stock underperform the Sensex over recent months.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
10-Feb-2026 | Source : BSENewspaper intimation regarding Special Window for re-lodgement of transfer requests of Physical shares
General Updates
30-Jan-2026 | Source : BSEIntimation of executed share subscription and shareholders agreement (SSSHA) and Captive Power Agreement (CPA) for procuring electricity from First Energy 11 Private Limited
Announcement under Regulation 30 (LODR)-Newspaper Publication
28-Jan-2026 | Source : BSENewspaper Publication
Corporate Actions
No Upcoming Board Meetings
RPG Life Sciences Ltd has declared 250% dividend, ex-date: 27 Jun 25
No Splits history available
No Bonus history available
No Rights history available






